Carprogesic 50mg/ml Small Animal Solution for Injection for Cats and Dogs

Država: Velika Britanija

Jezik: angleščina

Source: VMD (Veterinary Medicines Directorate)

Aktivna sestavina:

Carprofen

Dostopno od:

Norbrook Laboratories Limited

Koda artikla:

QM01AE91

INN (mednarodno ime):

Carprofen

Farmacevtska oblika:

Solution for injection

Tip zastaranja:

POM-V - Prescription Only Medicine – Veterinarian

Terapevtska skupina:

Cats, Dogs

Terapevtsko območje:

Anti Inflammatory NSAID

Status dovoljenje:

Expired

Datum dovoljenje:

2007-08-02

Lastnosti izdelka

Revised: September 2014
AN: 00670/2013
Page 1 of 6
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Carprogesic 50mg/ml Small Animal Solution for Injection for Cats and
Dogs
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each ml contains
ACTIVE SUBSTANCE:
Carprofen
50mg
EXCIPIENTS:
Benzyl Alcohol
10mg
Sodium Formaldehyde Sulphoxylate
2.5mg
For a full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Solution for Injection
A clear colourless to pale yellow solution
4.
CLINICAL PARTICULARS
4.1.
TARGET SPECIES
Dogs and Cats
4.2.
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
DOGS:
For
the
control
of
post-operative
pain
and
inflammation
following
orthopaedic and soft tissue (including intraocular) surgery.
CATS: For the control of post-operative pain following
ovariohysterectomy and soft
tissue surgery.
Revised: September 2014
AN: 00670/2013
Page 2 of 6
4.3.
CONTRAINDICATIONS
Do
not
use
in
animals
suffering
from
cardiac,
hepatic
or
renal
disease
or
gastrointestinal problems, where there is a possibility of
gastrointestinal ulceration
or bleeding, or hypersensitivity to carprofen or any other NSAIDs or
any excipients
of this product. As with other NSAIDs there is a risk of rare renal or
idiosyncratic
hepatic adverse events.
Do not use after surgery which was associated with considerable blood
loss.
Do not use in cats on repeated occasions.
Do not use in cats less than 5 months of age.
Do not use in dogs less than 10 weeks of age.
See also section 4.7.
4.4.
SPECIAL WARNINGS FOR EACH TARGET SPECIES
In the cat, due to the longer half-life, and narrower therapeutic
index, particular
care should be taken not to exceed the recommended dose and the use of
a
graduated 1ml syringe is recommended to measure the dose accurately.
4.5.
SPECIAL PRECAUTIONS FOR USE
i)
Special precautions for use in animals
Do
not
exceed
the
recommended
dose
or
duration
of
treatment
especially in the cat.
Use in aged dogs and cats, may involve additional risk. If such use
cannot be avoided, such animals may re